1-4 of 4
Martin Trbusek, Dr., PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Impact of NOTCH1 Hotspot Mutation in TP53 -Mutated Patients with Chronic Lymphocytic Leukemia

Barbara Kantorova, M.S., Jitka Malcikova, PhD, Veronika Navrkalova, M.S., PhD, Jana Smardova, Prof., MD PhD, Kamila Brazdilova, M.S., Karla Plevova, M.S., PhD, Eva Diviskova, M.S., Marek Borsky, M.S., Sarka Pavlova, M.S., PhD, Nikola Tom, M.S., Karol Pal, M.S., Martin Trbusek, Dr., PhD, Alexandra Oltova, Dr., Yvona Brychtova, MD PhD, Michael Doubek, Prof., MD PhD, Jiri Mayer, Prof., MD PhD, Sarka Pospisilova, Prof., Dr., PhD
Journal: Blood
Blood (2014) 124 (21): 3283.
https://doi.org/10.1182/blood.V124.21.3283.3283
Published: 2014
Journal Articles

Clonal Evolution and Therapy Related Selection Of TP53 Mutations In Chronic Lymphocytic Leukemia Patients

Karla Plevova, MSc., Jitka Malcikova, Dr., PhD., Martin Trbusek, Dr., PhD, Sarka Pavlova, MSc., PhD., Ludmila Sebejova, Dr., Boris Tichy, Dr., PhD., Michael Doubek, Prof., Yvona Brychtova, MD, PhD, Jiri Mayer, Prof., Sarka Pospisilova, Prof.
Journal: Blood
Blood (2013) 122 (21): 4126.
https://doi.org/10.1182/blood.V122.21.4126.4126
Published: 2013
Journal Articles

Mutational Analysis of TP53 Gene in Chronic Lymphocytic Leukemia: Comparison of Different Methodological Approaches

Barbara Kantorova, MSc., Jitka Malcikova, Dr., PhD., Jana Kminkova, PharmD., Veronika Navrkalova, MSc., Barbora Dvorakova, MSc., Boris Tichy, Dr., PhD., Jana Smardova, Prof., Martin Trbusek, Dr., PhD., Sim Truong, PhD., Katerina Stano-Kozubik, PhD., Nikola Tom, MSc., Karol Pal, MSc., Ludmila Sebejova, Dr., Nancy Patten, PhD., Lin Wu, PhD., Michael Doubek, M.D., PhD., Prof., Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD., Prof.
Journal: Blood
Blood (2012) 120 (21): 3911.
https://doi.org/10.1182/blood.V120.21.3911.3911
Published: 2012
Journal Articles

Inhibition of Chk1 Kinase Sensitizes Leukemia and Lymphoma Cell Lines with TP53 M utations to Chemotherapy.

Jana Zemanova, Ludmila Sebejova, Dr., Ondrej Hylse, Kamil Paruch, Ph.D., Sarka Pavlova, Jiri Mayer, M.D., PhD., Prof., Sarka Pospisilova, Dr., PhD, Prof., Martin Trbusek, Dr., PhD.
Journal: Blood
Blood (2012) 120 (21): 2460.
https://doi.org/10.1182/blood.V120.21.2460.2460
Published: 2012